The goal of this research is to develop novel electrophoresis media for large DNA separation (more than 50 kbp) in continuous electric fields, thereby replacing the need to use expensive and slow pulsed-field equipment. The proposed media formulations may obviate the need for pulsed fields by achieving new mechanisms of separation in electrophoresis. The formulations are based on a reversible micro gel technology that allows easy and reproducible formation of matrices. Phase I is directed toward evaluating the feasibility of several proposed formulations for DNA separation. The specific objectives of Phase I are, for each proposed media formulation, (1) to determine synthesis conditions to achieve suitable pore sizes, (2) to determine methods to prepare stable, reproducible matrices, (3) to determine how resolution of large DNA (20 kbp - 2.2 mbp) is affected by pore and particle size in our matrices, and (4) to determine how separations by the matrices compare with current PFE techniques. The most attractive formulation(s) from Phase I will be developed and optimized in Phase II for increased resolution and compatibility with standard techniques of DNA detection and recovery.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43HG001338-01
Application #
2209665
Study Section
Special Emphasis Panel (ZRG7-SSS-2 (01))
Project Start
1995-09-01
Project End
1996-05-31
Budget Start
1995-09-01
Budget End
1996-05-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Aclara Biosciences, Inc.
Department
Type
DUNS #
City
Mountain View
State
CA
Country
United States
Zip Code
94043